Abstract
Background
Considering that prehypertension is associated with an increase in cardiovascular risk, hypoadiponectinemia seems to be a predictor of hypertension.
Hypothesis
This study investigated whether adiponectin plasma levels are affected in Brazilian obese prehypertensives compared with those in normotensives and hypertensives.
Methods
The study involved 96 multiethnic obese subjects (mean age = 42.8–11.9 years; BMI = 35.7–7.3 kg/m2). Fasting plasma adiponectin and serum insulin were determined by radioimmunoassay. Insulin resistance was estimated by HOMA‐IR. Blood pressure was recorded using a calibrated automated sphygmomanometer.
Results
Adiponectin concentrations were significantly lower in prehypertensives compared with those in normotensives, but hypertensives exhibited the lowest adiponectin concentrations of all. Regarding the values of HOMA‐IR, both prehypertensives and hypertensives were significantly more insulin resistant when compared with normotensives. When normotensives and prehypertensives were classified according to the 50th percentile of adiponectin (≤ vs > 6.5 mg/ml) a logistic regression was performed to estimate the association of this adipokine with hypertension, the lower the plasma adiponectin values, the greater the association. A multivariate linear regression analysis adjusted for cardiometabolic factors showed that systolic blood pressure increased by 1.612 mm Hg for 1 µg/mL reduction in adiponectin plasma levels (P < 0.01).
Conclusion
Our findings have shown that hypoadiponectinemia is associated with prehypertension in obese individuals of multiethnic origin. Copyright © 2010 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (168.9 KB).
References
- 1. Vasan RS, Larson MG, Leip EP, et al. Impact of high‐normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291–1297. [DOI] [PubMed] [Google Scholar]
- 2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252. [DOI] [PubMed] [Google Scholar]
- 3. Kshirsagar AV, Carpenter M, Bang H, et al. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006; 119: 133–141. [DOI] [PubMed] [Google Scholar]
- 4. Sipahi I, Tuzcu EM, Schoenhagen P, et al. Effects of normal, pre‐hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006; 48: 833–838. [DOI] [PubMed] [Google Scholar]
- 5. Francischetti EA, Genelhu VA. Obesity‐hypertension: an ongoing pandemic. Int J Clin Pract 2007; 61: 269–280. [DOI] [PubMed] [Google Scholar]
- 6. Chow W‐S, Cheung BMY, Tso AWK, et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5‐year prospective study. Hypertension 2007; 49: 1455–1461. [DOI] [PubMed] [Google Scholar]
- 7. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 84–89. [DOI] [PubMed] [Google Scholar]
- 8. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose‐specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83. [DOI] [PubMed] [Google Scholar]
- 9. Papadopoulos DP, Makris TK, Krespi PG, et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens 2005; 7: 729–733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Francischetti EA, Celoria BM, Duarte SF, et al. Hypoadiponectinemia is associated with blood pressure increase in obese insulin‐resistant individuals. Metabolism 2007; 56: 1464–1469. [DOI] [PubMed] [Google Scholar]
- 11. Parra FC, Amado RC, Lambertuci JR, et al. Color and genomic ancestry in Brazilians. PNAS 2003; 100: 177–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419. [DOI] [PubMed] [Google Scholar]
- 13. Schillaci G, Pirro M. Hypoadiponectinemia: a novel link between obesity and hypertension? Hypertension 2007; 49: 1217–1229. [DOI] [PubMed] [Google Scholar]
- 14. Adamczak M, Wiecek A, Funahashi T, et al. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003; 16: 72–75. [DOI] [PubMed] [Google Scholar]
- 15. Iwashima Y, Katsuya T, Ishikawa K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318–1323. [DOI] [PubMed] [Google Scholar]
- 16. Mohlig M, Wegewitz U, Osterhoff M, et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res 2002; 34: 655–658. [DOI] [PubMed] [Google Scholar]
- 17. Anderson EA, Hoffman RP, Balon TW, et al. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87: 2246–2252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Rahmouni K, Morgan DA, Morgan GA, et al. Hypothalamic P13 kinase and MAP kinase differentially mediate regional sympathoactivation to insulin. J Clin Invest 2004; 114: 652–658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–194. [DOI] [PubMed] [Google Scholar]
- 20. Fasshauer M, Klein J, Neumann S, et al. Adiponectin gene expression is inhibited by beta‐adrenergic stimulation via protein kinase A in 3‐T3‐L1 adipocytes. FEBS Lett 2001; 507: 142–146. [DOI] [PubMed] [Google Scholar]
- 21. Massiera F, Bloch‐Faure M, Ceiler D, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001; 15: 2727–2729. [DOI] [PubMed] [Google Scholar]
- 22. Niskanen L, Laaksonen DE, Nyyssönen K, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004; 44: 859–865. [DOI] [PubMed] [Google Scholar]
- 23. Najjar SS, Scuteri A, Shetty V, et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2008; 51: 1377–1383. [DOI] [PMC free article] [PubMed] [Google Scholar]